News

24/7 Wall St. on MSN1d
Eli Lilly Will Be the Next $1 Trillion Stock
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...
Eli Lilly Stock (LLY) is Stronger as it Fights for Alzheimer’s Drug Approval in Europe
Shares in pharmaceuticals giant Eli Lilly (LLY) were looking perkier today after it ramped up its battle to get a key ...
Trade Tracker: Bill Baruch buys Eli Lilly, McDonald's, and Palantir
Bill Baruch, founder & president at Blue Line Capital, joins CNBC’s 'Halftime Report' to detail his latest portfolio moves.
Eli Lilly: Positioned For Robust Q1 As Orforglipron Enhances Long-Term Outlook
Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...
This veteran investor is known for spotting winning stocks. Here’s why he’s all-in on Nvidia and Eli Lilly.
Stock-market veteran Louis Navellier, the chairman and founder of investment firm Navellier & Associates, is well-known for ...
Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs
Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...
Why It Makes Sense To Buy Eli Lilly Stock At $840
The trial met its primary objectives, showing the pill’s effectiveness in helping patients with Type 2 diabetes achieve ...
Lilly requests EMA to re-examine Alzheimer's drug recommendation
Eli Lilly has requested Europe's medicines regulator to re-examine its opinion on the company's Alzheimer's drug, the agency ...